Use of gene-modified keratinocytes and fibroblasts to enhance regeneration in a full skin defect

Langenbecks Arch Surg. 2011 Apr;396(4):543-50. doi: 10.1007/s00423-011-0761-3. Epub 2011 Mar 3.

Abstract

Background: With the development of cell-based gene transfer techniques, genetically modified human keratinocytes (Kc) and fibroblasts (Fb) have been proven to be a better choice in wound repair.

Methods: This study was designed to construct in one step a gene-modified artificial skin by a genetically engineered Kc expressing PDGF-BB and Fb expressing VEGF(165) and bFGF. The wound healing effect in a full-thickness wound model was then observed. Unmodified artificial skin served as control. On the post-operative days 7, 14, and 21, residual wound area was calculated and skin wound tissues were subjected to biopsy for further investigation.

Results: Compared with unmodified artificial skin, gene-modified artificial skin resulted in a reduced wound contraction and a well-organized human epidermis and better formed dermis.

Conclusions: The results suggest that our two-layer, gene-modified artificial skin improved both vascularization and epidermalization for skin regeneration. This technique could bring about a new approach in the treatment of burns and chronic wounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Chondroitin Sulfates / genetics
  • Chondroitin Sulfates / therapeutic use*
  • Collagen / genetics
  • Collagen / therapeutic use*
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblasts / physiology*
  • Genetic Enhancement / methods*
  • Keratinocytes / physiology*
  • Mice
  • Mice, Nude
  • Platelet-Derived Growth Factor / genetics
  • Proto-Oncogene Proteins c-sis
  • Skin, Artificial*
  • Vascular Endothelial Growth Factor A / genetics
  • Wound Healing / genetics*

Substances

  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • integra artificial skin
  • Fibroblast Growth Factor 2
  • Becaplermin
  • Chondroitin Sulfates
  • Collagen